Medistep Healthcare Ltd
NSE: MEDISTEP · Other · sector
₹22.00NSE close 2026-10-26
Key numbers
Market cap₹31 cr
Price₹22.00
52w high / low₹30 / ₹16
P/E4.7xSector median 14.4x
P/B0.8xSector median 1.7x
Book value₹26.6
Dividend yield–Sector median 0.37%
ROE15.8%Sector median 13.8%
ROCE19.2%Sector median 19.6%
OPM11.6%Sector median 10.4%
Debt / equity0.14xSector median 0.29x
EV/EBITDA4.3xSector median 8.4x
Interest cover33.2x
Current ratio4.03x
Sales growth 3y–Sector median +7.7%
Profit growth 3y–Sector median +16.6%
PEG–
Last 12 months to Mar 2026, Standalone. "Sector median" = middle value of 688 companies in Other (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹1 cr vs borrowings ₹5 cr (FY26): borrowings are higher by ₹5 cr.
- Operating profit covered interest 33.2x in the last 12 months.
- Other income was 0% of net profit in the last 12 months.
- No dividend in the last 1 financial years.
- Price ₹22.00 on 2026-10-26: -26.7% from the 52-week high, +33.3% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹45.45 · low ₹17.20
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Sep 2025 | Mar 2026 |
|---|---|---|
| Revenue | 35 | 36 |
| EBITDA | 4 | 4 |
| OPM % | 11.4% | 11.9% |
| Other income | 0 | 0 |
| Net profit | 3 | 3 |
| EPS (₹) | 2.61 | 2.12 |
Standalone figures where filed. Latest quarter Mar 2026.
Profit & loss (yearly)
| ₹ cr | FY26 | TTM |
|---|---|---|
| Revenue | 71 | 71 |
| EBITDA | 8 | 8 |
| Net profit | 6 | 6 |
| EPS (₹) | 4.68 | 4.68 |
| Dividend / share (₹) | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | – | – | – |
| Net profit | – | – | – |
| EPS | – | – | – |
| Share price | – | – (2y) | -22.5% |
Balance sheet
| ₹ cr | FY26 |
|---|---|
| Shareholders' equity | 38 |
| Borrowings | 5 |
| Cash & equivalents | 1 |
| Total assets | 50 |
| Fixed assets | 0 |
| Investments | 0 |
| Receivables | 39 |
| Inventory | 6 |
| Payables | 4 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY26 |
|---|---|
| Cash from operations | -19 |
| Cash from investing | -0 |
| Cash from financing | 19 |
| Capex | 0 |
| Free cash flow | -19 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY26 |
|---|---|
| ROE % | 15.8% |
| ROCE % | 19.2% |
| Debtor days | 203 |
| Inventory days | 36 |
| Payable days | 22 |
| Cash conversion cycle (days) | 217 |
| Working capital days | 194 |
Peers in Other
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| TSFINV | ₹8,585 cr | 17.6x | 1.4x | 8.4% | 3.6% | 20.5% | +121.7% | 2.30% |
| KRISHANA | ₹6,339 cr | 39.9x | 11.3x | 41.6% | 23.2% | 12.6% | +95.7% | 0.05% |
| MARINE | ₹5,431 cr | 84.2x | 11.0x | 14.3% | 18.0% | 10.8% | +25.6% | 0.07% |
| ZOTA | ₹4,139 cr | – | 6.0x | -22.5% | -12.4% | -0.5% | +56.7% | 0.07% |
| AIMTRON | ₹3,319 cr | 71.7x | 17.1x | 28.0% | 31.8% | 21.8% | – | – |
| ACCORD | ₹2,984 cr | – | 261.7x | 12.4% | 12.0% | 2.4% | – | – |
| MONOLITH | ₹2,646 cr | 64.6x | 24.3x | 36.0% | 48.7% | 24.4% | – | – |
| UTSSAV | ₹2,390 cr | 40.2x | 14.1x | 43.4% | 54.7% | 7.9% | – | – |
| BETA | ₹2,200 cr | 40.6x | 5.0x | 16.4% | 17.0% | 20.8% | – | – |
| MEDISTEP | ₹31 cr | 4.7x | 0.8x | 15.8% | 19.2% | 11.6% | – | – |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | |
| Industry | Other |
| Sub-industry | |
| Symbol | MEDISTEP |
| BSE code | – |
| ISIN | INE0UOY01019 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-24 from NSE company filings (XBRL: Integrated Filing - Financials + financial results); price = NSE close 2026-10-26.